Skip to main content


International Day of Immunology

International Day of Immunology 2020

back to Janssen EMEA stories

For the PEACE Within – our commitment to helping people living with immune-mediated inflammatory
diseases (IMIDs) is more important today than ever before.

– Collage with Janssen employees across EMEA who are committed to supporting International Day of Immunology.

Infographic showing immune-mediated inflammatory diseases can impact up to 1 in 10 people with circles containing psoriasis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, lupus and psoriatic arthritis.

There are up to 70 million people in Europe living with IMIDs such as psoriasis, rheumatoid arthritis, Crohn’s disease, psoriatic arthritis, lupus and ulcerative colitis. These conditions all share a common link – an imbalance in the immune system that leads to chronic inflammation.

At Janssen, we understand the debilitating, physical impact of IMIDs such as pain, fatigue and the inability to perform everyday tasks. We also know that many people living with IMIDs also suffer from stigma, isolation and psychological issues, which are likely to be exacerbated in the current, uncertain environment.

That’s why this International Day of Immunology provides a timely moment to show our support to people living with IMIDs. The PEACE Within represents Janssen’s commitment to supporting people living with IMIDs who have to suffer every day for the rest of their lives. Join us by taking a moment to reach out to those you know living with IMIDs and offer them a virtual helping hand during this uncertain time.

The Janssen Immunology team is dedicated and determined to improve the lives of people with IMIDs. Through our unceasing research, we continue to increase our understanding of the immune system, to discover and develop better medicines, so that one day we will be able to live in a world where IMIDs are a thing of the past.

Quote card of Dr. Jaime Oliver Vigueras, Janssen’s EMEA Immunology Therapy Area Lead.

back to Janssen EMEA stories


1. Cooper G, Bynumb M and Somersc E. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of
disease. J Autoimmune 2009;33:197–207.

2. Griffiths C, van der Walt J, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol 2017;177(1):e4–e7.

3. Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A synopsis. Am J Manag Care 2014;20:S128–35.

4. Ng SC, Shi HY, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Lancet 2017;390:2769–78.

5. Lupus Foundation of America. Statistics on Lupus. Available at: Last accessed April 2020.

6. Scotti L, Franchi M, et al. Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2018;48(1):28–34.